Literature DB >> 31571012

The clinical significance of distal spread differs according to the primary tumor location in rectal cancer.

Kaoru Abe1, Yoshifumi Shimada2, Hidehito Oyanagi1, Ryoma Yagi1, Masato Nakano1, Hitoshi Kameyama1, Hitoshi Nogami3, Satoshi Maruyama3, Yasumasa Takii3, Toshifumi Wakai1.   

Abstract

PURPOSE: Treatment strategies of rectal cancer differ between tumors located above (RS/Ra) and below (Rb) the peritoneal reflection. Based on the extent of distal spread (DS), the Japanese Society for Cancer of Colon and Rectum proposed an optimal distal margin in RS/Ra and Rb tumors. In this study, we investigated the clinical significance of DS between RS/Ra and Rb tumors.
METHODS: We analyzed 287 stage I-III rectal cancer patients who underwent curative intent resection without preoperative therapy. DS and other pathological factors were evaluated using whole-mount sections. To investigate the clinical significance of DS in RS/Ra and Rb tumors, clinicopathological variables, including DS, were analyzed for the survival outcome according to the tumor group.
RESULTS: DS was detected in 20 out of 185 (11%) patients with RS/Ra tumors and 8 out of 102 (8%) patients with Rb tumors. DS was not significantly associated with the overall survival (OS) or relapse-free survival (RFS) in RS/Ra tumors, but was an independent prognostic factor for the OS and RFS in Rb tumors (P = 0.002 and 0.007, respectively).
CONCLUSIONS: The clinical significance of DS differs between RS/Ra and Rb tumors. DS is associated with a worse survival in Rb tumors, but not in RS/Ra tumors.

Entities:  

Keywords:  Clinical significance; Distal spread; Rectal cancer; Whole-mount section

Mesh:

Year:  2019        PMID: 31571012     DOI: 10.1007/s00595-019-01882-x

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  26 in total

1.  Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ.

Authors:  Chihiro Ono; Keigo Yoshinaga; Masayuki Enomoto; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2002-06       Impact factor: 4.585

2.  Flattened tumor requires a more careful attention for residual distal cancer spread in locally advanced lower rectal carcinoma after chemoradiotherapy.

Authors:  Osamu Kinoshita; Masayoshi Nakanishi; Yasutoshi Murayama; Yoshiaki Kuriu; Yukihito Kokuba; Eigo Otsuji
Journal:  Dig Surg       Date:  2015-03-28       Impact factor: 2.588

3.  Effect of preoperative chemotherapy on distal spread of low rectal cancer located close to the anus.

Authors:  Akihiro Kondo; Yuichiro Tsukada; Motohiro Kojima; Yuji Nishizawa; Takeshi Sasaki; Yasuyuki Suzuki; Masaaki Ito
Journal:  Int J Colorectal Dis       Date:  2018-09-13       Impact factor: 2.571

4.  Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision.

Authors:  J Hida; M Yasutomi; T Maruyama; K Fujimoto; T Uchida; K Okuno
Journal:  J Am Coll Surg       Date:  1997-06       Impact factor: 6.113

5.  Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery.

Authors:  K Shirouzu; H Isomoto; T Kakegawa
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

6.  Pathological study of distal mesorectal cancer spread to determine a proper distal resection margin.

Authors:  Gao-Ping Zhao; Zong-Guang Zhou; Wen-Zhang Lei; Yong-Yang Yu; Cun Wang; Zhao Wang; Xue-Lian Zheng; Rong Wang
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

7.  Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer.

Authors:  N Scott; P Jackson; T al-Jaberi; M F Dixon; P Quirke; P J Finan
Journal:  Br J Surg       Date:  1995-08       Impact factor: 6.939

8.  A prospective evaluation of distal margins in carcinoma of the rectum.

Authors:  A M Vernava; M Moran; D A Rothenberger; W D Wong
Journal:  Surg Gynecol Obstet       Date:  1992-10

9.  Whole-mount pathologic analysis of rectal cancer following neoadjuvant therapy: implications of margin status on long-term oncologic outcome.

Authors:  James J Mezhir; Jinru Shia; Elyn Riedel; Larissa K Temple; Garrett M Nash; Martin R Weiser; Philip B Paty; W Douglas Wong; Jose G Guillem
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

10.  Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.

Authors:  Nathalie Guedj; Léon Maggiori; Nicolas Poté; Emma Norkowski; Jérôme Cros; Pierre Bedossa; Yves Panis
Journal:  Hum Pathol       Date:  2016-02-10       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.